The Hill.The new method of administering the Jynneos smallpox vaccine allows health officials to administer more doses to more people to avoid straining the already limited supply of vaccine.
By administering the vaccine intradermally, versus subcutaneously, health officials can vaccinate five times as many people.The administration approved the change in vaccine delivery earlier this month, but jurisdictions are still transitioning to the new method, with some saying they need more guidance from the federal government before proceeding.
Administration officials say the Centers for Disease Control and Prevention will be providing additional training and technical assistance to health authorities to ensure they can maximize the number of doses from a single vial.
Another 150,000 Jynneos vials, with 750,000 potential new doses, are expected to arrive in September, after the Biden administration fast-tracked a shipment that was scheduled to arrive in October.